Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status [PDF]
The incidence of Japanese cedar pollinosis is increasing significantly in Japan, and a recent survey suggested that about 40% of the population will develop this disease. However, spontaneous remission is rare.
Daiju Sakurai +2 more
exaly +5 more sources
Asthma in Patients With Japanese Cedar Pollinosis [PDF]
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea ...
Akihiko Tanaka +3 more
doaj +7 more sources
Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis [PDF]
Sublingual immunotherapy for Japanese cedar pollinosis can improve the symptoms of allergic rhinitis and modify its natural course. However, sublingual immunotherapy requires a long treatment period and some patients do not respond to treatment.
Riyo Yoneda +8 more
doaj +3 more sources
Analysis of factors associated with cedar pollen sensitization and development of pollinosis in a young Japanese adult population [PDF]
Background: Genetic and environmental factors are proposed to be involved in cedar pollen allergy sensitization and onset. The impact of these factors will provide key information for the prevention of cedar pollen sensitization and allergy onset, which ...
Sawako Masuda +2 more
exaly +6 more sources
Are Respiratory Viruses Involved in Preseasonal Symptoms or Severity in Japanese Cedar Pollinosis? [PDF]
Background Respiratory virus infections are involved in asthma exacerbations. However, there are no reports of the relationship between respiratory virus infections and Japanese cedar pollinosis.
Hirokuni Otsuka M.D. +4 more
doaj +3 more sources
Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches [PDF]
Fumio Takaiwa1,2 1Soul Signal Institute, Kojyohama, Shiraoi, Hokkaido, 059-0641, Japan; 2Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, 305-8602, JapanCorrespondence: Fumio TakaiwaInstitute of
Fumio Takaiwa
exaly +4 more sources
Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis [PDF]
Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan.
Masahiro Gotō +2 more
exaly +4 more sources
Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season [PDF]
Background and objective Nasal symptoms of allergic rhinitis can be reduced with allergen‐specific subcutaneous immunotherapy (SCIT). However, the mechanisms underlying the effectiveness of SCIT for Japanese cedar pollinosis are not well understood.
Kuninori Otsuka +3 more
doaj +2 more sources
Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment
Pollen from many tree species in the Cupressaceae family is a well-known cause of seasonal allergic diseases worldwide. Japanese cedar pollinosis and Japanese cypress pollinosis, which are caused by pollen from Japanese cedar (Cryptomeria japonica) and ...
Toshihiro Osada, Mitsuhiro Okano
exaly +3 more sources
Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy [PDF]
Background and Objective Nasal symptoms were reduced following allergen‐specific sublingual immunotherapy (SLIT) for allergic rhinitis. The mechanisms underlying the effectiveness of SLIT for Japanese cedar pollinosis are poorly understood.
Kuninori Otsuka +3 more
doaj +2 more sources

